Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information , 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)
ABSTRACTWe investigated the role of DARPP-32 in mediating changes in phosphorylation after sarin exposure. Wild type mice and mice bearing a targeted disruption of the gene for DARPP-32 were exposed to sarin; levels of brain phosphoproteins were measured. Mice receiving 1.0 x LD 50 dose of sarin displayed motor convulsions. No significant change in phosphorylation level of T75 DARPP-32 was observed in brains of wild type mice. Also, no significant changes in phosphorylation were observed in the brains of wild type or DARPP-32 knockout mice after 0.5 x LD 50 sarin. At a sarin dose of 1.0 x LD 50 a significant increase in CREB phosphorylation was observed. One difference was noted in brain phosphorylation between wild type and DARPP-32 knockout mice. The presence of DARPP-32 significantly affected the ability of sarin to alter phosphorylation of the AMPA receptor GluR1 at S831. An increase in phosphorylation measured in wild type mouse brain after sarin was significantly attenuated in the brain of DARPP-32 knockout mice, indicating that DARPP-32 may modulate the extent to which S831 responses are induced by sarin. The results of this study do not support the hypothesis that changes in phosphorylation levels of T75 DARPP-32 are necessary for phosphorylation changes observed in brain after a 1.0 x LD 50 dose of sarin. iii
SUBJECT TERMS
ACKNOWLEDGEMENTSThe expert advice and technical help of Dr. James O'Callaghan (CDC-NIOSH) in adapting the microwave applicator for use in mice is gratefully acknowledged. The excellent technical assistance of Peter Ingrassia (Rockefeller University) in the genotyping and shipment of mice for these studies is also gratefully acknowledged.v ABSTRACT Organophosphorus (OP) nerve agents exert acute effects by inhibiting the enzyme acetylcholinesterase in the central and peripheral nervous systems. Inhibition of acetylcholinesterase results in accumulation of acetylcholine and, which in turn causes overstimulation of nicotinic and muscarinic receptors. Previous study indicated that treatment of rats with the nerve agent sarin both at a convulsive dose (1.0 x LD 50 ) and a sub-convulsive threshold dose...